1. Introduction {#sec1}
===============

Acute intermittent porphyria (AIP, OMIM 176000) is a rare autosomal dominant disorder, caused by a partial deficiency of porphobilinogen deaminase (PBGD), with the alternative name hydroxymethylbilane synthase (HMBS), the third enzyme in the heme biosynthetic pathway \[[@B1]\]. The presentation of AIP is highly variable and the symptoms are nonspecific. The typical manifestations of AIP are intermittent attacks of abdominal pain, constipation, or confusion and convulsion occurs in some individuals \[[@B2]\]. In mainland of China, hematin is not available to treat acute porphyria. Fortunately, with high carbohydrate intake and the avoidance of harmful drugs, our patients almost completely recovered from their acute attacks, although their recovery required several weeks or months. The clinical features of AIP have been described in various case reports and small series, while larger studies have focused on particular aspects of the disease, such as genetics \[[@B2]--[@B5]\]. In addition, rare study has addressed the psychosocial consequences of AIP despite the apparent severity of symptoms and substantial changes to lifestyle necessary to avoid episodes of acute attack \[[@B6]\]. Bullinger et al. defined health-related quality of life (HRQoL) as "the impact of perceived health on an individual\'s ability to live a fulfilling life," and it is now an important health outcome measure \[[@B7]\]. The MOS 36-item Short-Form Health Survey (SF-36) is a popular HRQoL measure that has been translated and validated for Chinese adults in Hong Kong (HK) \[[@B8], [@B9]\]. The effects of the SF-36 scores on consultation rates were stronger than those of sociodemographic and morbidity factors \[[@B8], [@B10]\]. Impact of Event Scale-Revised (IES-R) is a questionnaire that assesses posttraumatic stress disorder-related symptoms (PTSS) for the previous one-week period \[[@B15]\]. Here we reported findings of 27 patients with AIP in China, which were designed to record clinical features, methods of treatment impact on quality of life (QoL), and psychological condition of these AIP patients. To our knowledge, there were no such reports in Chinese population.

2. Compliance with Ethics Guidelines {#sec2}
====================================

The study design was approved by the Ethics Committee of the Institutional Review Board in Peking Union Medical College Hospital (PUMCH).

3. Patients and Methods {#sec3}
=======================

3.1. Patients {#sec3.1}
-------------

From January 2014 to December 2016, a total of 60 patients were diagnosed with acute intermittent porphyria in the emergency center and the gastroenterology department of PUMCH. The following diagnostic criteria were used: (1) acute attack symptoms and (2) being positive for urine porphobilinogen (PBG). Among the 60 AIP patients, 30 agreed to have genetic testing for PBGD gene mutations, 29 of 30 have proven the PBGD gene mutation, 10 of them have been reported \[[@B2]\], and 19 of them will be described in our other paper.

3.2. Procedures {#sec3.2}
---------------

Physicians determined eligible participants, informed them briefly about the study by phone or WeChat, and requested participation in the study. They got the answer link and a detailed explanation about the study via WeChat, with the link including self-report questionnaires. The questionnaires and medical information sheets were assigned an identification number; we did not make a correspondence list to ensure that participants remained anonymous. We contacted 28 of 29 who have proven PBGD gene mutation, and 27 of 28 patients finished the questionnaire.

3.3. Quality of Life Indices {#sec3.3}
----------------------------

Health-related quality of life (HRQoL) was measured using Chinese version 1.0 of the SF-36 Health Survey \[[@B11]\] developed in 1997. The SF-36 \[[@B12], [@B13]\] is made up of 36 questions that correspond to eight dimensions: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH). All dimensions can be further classified into the physical domain (PF, RP, BP, and GH) and the mental domain (VT, SF, RE, and MH). The scores for each category scale from 0 to 100, in which 100 represents the best health status, while 0 represents the worst health status. The SF-36 scores can also be expressed as two summary measures, the physical component summary (PCS) and the mental component summary (MCS), which provides a measure of the overall effect of physical and mental impairment, with higher scores indicating better QoL \[[@B14]\].

3.4. Impact of Event Scale-Revised (IES-R) {#sec3.4}
------------------------------------------

IES-R is a 22-item self-report questionnaire that assesses posttraumatic stress disorder-related symptoms (PTSS) for the previous one-week period \[[@B15]\]. Symptoms are rated on a 5-point Likert scale (0--4), with higher scores indicating a high degree of PTSS. The IES-R consists of three components: intrusion, avoidance, and hyperarousal. We used the Chinese version of the IES-R \[[@B16]\] which demonstrated satisfactory validity and test-retest reliability. There is no specific cut-off score of IES-R. We classified participants to low PTSS (IES-R score \< 26) or high PTSS (IES-R score ≥ 26) for analysis \[[@B17]--[@B19]\]; Cronbach\'s *α* was 0.95.

3.5. Genetic Testing {#sec3.5}
--------------------

The molecular genetic testing of PBGD gene was performed by direct sequencing. All 14 exons of the PBGD gene and a minimum of 20 base pairs of flanking intronic DNA for each exon were amplified by polymerase chain reaction (PCR) (Tiangen Biotech, Beijing, China) and subsequently sequenced using the BigDye Terminator Cycle Sequencing Kit version 3.1 (ABI Biosystems) on ABI PRISM 3730 Sequence Analyzer according to the manufacturer\'s instructions.

3.6. Statistics {#sec3.6}
---------------

All statistical analyses were performed using SPSS software (IBM SPSS for Windows, version 16.0, SPSS, Inc., Chicago, IL) for descriptive analysis. Chi-square tests were employed for categorical variables, while parametric Student\'s *t*-tests or Mann--Whitney *U* tests were used for continuous counterparts, as appropriate. For all comparisons, a *P* value \< 0.05 was considered to represent a significant difference. All statistical tests were 2-sided. The scores between categorical groups were compared using a *t*-test or one-way ANOVA as appropriate.

4. Results {#sec4}
==========

4.1. Patients {#sec4.1}
-------------

The study cohort contained 27 patients (median age: 29 years, range: 21--47 years). The 27 patients were derived from 25 families.

4.2. Age at Onset and the Frequency of Acute Attacks {#sec4.2}
----------------------------------------------------

Age at onset and the frequency of acute attacks of AIP patients were summarized in [Table 1](#tab1){ref-type="table"}. The median age at onset of symptoms was 26 years (range: 18--46 years), and the duration of history was 3.76 years (range: 1--8 years). 17/27 had acute attacks in the last year. The median frequency of acute attacks in the last year was 1.70 times (0--10 times), and the duration of every attack was 11.4 days (3--20 days).

4.3. Symptoms {#sec4.3}
-------------

The symptoms of AIP were summarized in descending order of frequency in [Table 2](#tab2){ref-type="table"}. Other manifestations were shown such as dysphagia (*n* = 1). 9/27 had complaints in intermission, including fatigue, pain, or numbness.

4.4. Working Status {#sec4.4}
-------------------

12/27 patients stayed at home, 4/27 worked at home, and 13/27 were employed. 22/27 thought they could work as usual.

4.5. Treatment {#sec4.5}
--------------

9/27 patients were treated with induced menopause lasting 1-2 years and 4/27 received the treatment of hematin (obtained in Hong Kong or Taiwan for once or twice).

4.6. Quality of Life {#sec4.6}
--------------------

Scores for each subscale were PF, 85.74 ± 11.67 (91.83 with norm-based scoring \[[@B9]\], *P* = 0.01), RP, 64.81 ± 57.74 (82.43 \[[@B9]\], *P* = 0.13), BP, 77.96 ± 22.81 (83.98 \[[@B9]\], *P* = 0.18), GH, 51.67 ± 25.84 (55.98 \[[@B9]\], *P* = 0.39), VT, 57.96 ± 18.96 (60.27 \[[@B9]\], *P* = 0.53), SF, 85.65 ± 23.44 (91.19 \[[@B9]\], *P* = 0.23), RE, 69.13 ± 54.64 (71.67 \[[@B9]\], *P* = 0.81), MH, 65.19 ± 19.15 (72.79 \[[@B9]\], *P* = 0.049), PCS, 45.50 ± 10.39, and MCS, 47.76 ± 12.14.

Without acute attack with 2 significant subscales (PF and BP, *P* = 0.04) and 1 subscale trending toward significance than with acute attack group (GH with *P* = 0.05) and a lower PCS composite score (*P* = 0.001), one variable was associated with better QOL in the RP, working status (score of 35.42 for stay at home versus 88.33 for working; *P* = 0.02), as shown in Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"}.

College education, marital status, and symptom severity were not significantly different across the composite or any of the subscales ([Table 3](#tab3){ref-type="table"}).

4.7. Posttraumatic Stress Disorder {#sec4.7}
----------------------------------

Posttraumatic stress disorder (PTSD) was measured by the IES-R questionnaire. The mean IES-R score was 36.7 ± 11.8 points (26 with norm-based scoring \[[@B20], [@B21]\], *P* \< 0.001), and the average subscores were as follows: intrusion, 17.93 ± 5.78; avoidance, 18.48 ± 6.51; and hyperarousal, 13.26 ± 5.10.

We analyzed the clinical characteristics with IES-R score ([Table 5](#tab5){ref-type="table"}). Only one variable was associated with better IES-R in 1 subscale (intrusion score: 14.44 with acute attack versus 19.53 without acute attack, *P* = 0.03), as shown in [Table 5](#tab5){ref-type="table"}; neither were related to IES-R scores. College education, marital status, work status, and symptom severity were not significantly different across the composite or any of the subscales.

5. Discussion {#sec5}
=============

The clinical manifestations of acute porphyria are diverse and occur as intermittent attacks that may be life-threatening \[[@B5], [@B22]\]. Although there have been considerable advances in the molecular genetics, pathophysiology, and management of patients with AIP, little was known on the psychosocial consequences of their diagnosis \[[@B6], [@B23]\]. In the mainland of China, hematin is not available to treat AIP and acute attacks are likely to result in hospitalization to intake high carbohydrate \[[@B2]\] for weeks. And the patients must be aware of precipitating events and medications. These factors suggest that psychosocial aspects are important variables in understanding the AIP patient experience. This study was focusing on self-rated psychosocial aspects and quality of life issues in AIP.

Demographic characteristics of this study sample showed similar trends found in our previous paper \[[@B2]\], in which 10 of 27 were described. Gastrointestinal symptoms were the most frequently reported complaints (abdominal pain and constipation) and neurological manifestations symptoms were more frequent than described in medical recording ([Table 2](#tab2){ref-type="table"}, 13/27, 11/27 versus 10/36 \[[@B2]\], 5/36 \[[@B2]\]). Maybe some complaints would be ignored by Chinese clinicians.

It had been described that the perceived effects of 81 acute porphyria patients on quality of life and patient experience, depression, and particularly anxiety were more common than in the general population \[[@B23]\] (medical outcomes study general health questionnaire and EuroQol questionnaire). Our study used the SF-36 questionnaire and IES-R to assess the quality-of-life parameters and the prevalence of significant PTSD-related symptoms of the AIP patients.

The SF-36 has eight scales measuring eight domains of HRQoL; each scale consists of 2 to 10 items, and each item is rated on a two- to six-point scale. The two-factor structure was demonstrated in the general population: the physical health summary (PCS) and mental health summary (MCS) components could explain 60% of the total variance of the SF-36 scale scores and can be interpreted as outcome measures in clinical trials \[[@B14], [@B24]\]. We used the SF-36 scores of the survey to 2410 adults of the Chinese (HK) general population \[[@B9]\] as normal scores. Our study demonstrated that self-report SF-36 factors were significantly abnormal in AIP patients. The PF score and MH were lower than normal (85.74 versus 91.83, *P* = 0.001; 65.19 versus 72.79, *P* = 0.049, [Table 6](#tab6){ref-type="table"}), while other subscales had no significant difference. The MCS and the related subscales had no significant difference with general population. We also performed comparison with other data collected from a cross-sectional survey of 21,948 cases in China from December 2005 to January 2007 of nine provinces of mainland to study the association between BMI and HRQoL in Chinese adults \[[@B25]\]. The GH scores were lower than normal BMI group (51.67 versus 64.7, *P* = 0.015, [Table 6](#tab6){ref-type="table"}). Age, gender, social class gradient, and so forth had effect on the SF-36 scores \[[@B9]\]; most of AIP patients were young women (age: 21--47 years), and their BMI were normal or underweight, so the difference may be related to the age, sexuality, BMI, and area between general populations with AIP patients, and the difference differs from general population we choose ([Table 6](#tab6){ref-type="table"}); it needs larger scale; the scores of the total population and the scores for groups differ in age and sexuality.

The patients who worked had lower RP scores than those who stayed at home but not across all 4 subscales. Patients without acute attack in the last year had significantly higher PF and BP scores than those with acute attack, and 1 subscale trended toward significance (GH with *P* = 0.05) and a higher PCS composite score (*P* = 0.001). 2 of 10 had received induced menopause therapy so they avoided acute attack in the last year. It revealed that reducing the attack episode might reduce the physical effects on AIP patients.

Posttraumatic stress disorder was measured by the Impact of Event Scale-Revised questionnaire. The mean IES-R score was 36.7 ± 11.8 points (26 with norm-based scoring, *P* \< 0.001), and the average subscores were as follows: intrusion, 17.93 ± 5.78; avoidance, 18.48 ± 6.51; and hyperarousal, 13.26 ± 5.10.

The acute attacks of AIP had periodic occurrence without any signs and always occurred during menstruation \[[@B2], [@B5], [@B26]\]. The patients were afraid of attack and even nervous before every period. The prevalence of significant PTSD-related symptoms (IES-R ≥ 26) was reported \[[@B15], [@B19], [@B20], [@B27]\]. In our study, the AIP patients reported increased prevalence of PTSD-related symptoms. The patients without acute attack, at least in the last year, had better IES-R in intrusion score than those who had acute attacks. College education, marital status, and work status were not significantly different across the composite or any of the subscales. The acute attack might influence the PTSD-related symptoms of AIP patients for at least one year.

We contacted the patients via WeChat, because they could easily get the answer link and the detailed explanation about the study via WeChat, with the link including self-report questionnaires. So we got a high response rate (27/28). WeChat was a very famous and extensively used app. We could use it to follow the patients and do the questionnaire survey. It may be widely used to do the questionnaire research in the near future for it is convenient and could get the high response rate.

The prompt and accurate diagnosis of acute porphyria in China is limited by poor awareness among physicians. Measurements of urinary PBG, ALA, and porphyrins, plasma and fecal porphyrins, and erythrocyte PBG deaminase are important for the diagnosis and typing of porphyria, but in mainland of China almost none of the hospitals carry out these tests, so we use the genetic testing as the diagnostic test.

Our study has several limitations. Because AIP is a rare disease, this study was a single-center research and we only enrolled 27 cases. The results might be different from the large multicenter research. In mainland of China, hematin is not available to treat acute porphyria. 4/27 of our patients had accepted hematin treatment and could not use hematin in every attack, so we could not evaluate the relationship of hematin use with the quality of life or the PTSD symptoms.

We hope this research will help understand the impact of AIP on the quality of life of the patients from the north of China, and the new treatments that can reduce the acute attack times may help improve the quality of life.

6. Conclusion {#sec6}
=============

The main findings of our study were that AIP patients showed significant differences in the quality of life by SF-36 questionnaire with respect to general population. They had an impaired quality of life, particularly in physical domain. Reducing the acute attack episode might help improve the PCS score. The acute attacks coursed the PTSD-related symptoms. Clinicians should pay more attention to the mental health status and impaired quality of life of the AIP patients.
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###### 

Demographic characteristics of AIP patients.

  ------------------------------------------ -----------
  Age, yrs                                    
  18--39                                     25 (92.6)
  40--50                                     2 (7.4)
  Female                                     27 (100)
  Race (Han)                                 27 (100)
  Education                                   
  Postcollege                                6 (22.2)
  College graduate                           7 (25.9)
  High school graduate/GED                   4 (14.8)
  Junior high school graduate                8 (29.6)
  primary school education                   2 (7.4)
  Marital status                              
  Married                                    19 (70.4)
  Divorced or separated                      2 (7.4)
  Never married                              6 (22.2)
  Employment                                  
  Full-time                                  13 (48.1)
  Homemaker                                  4 (14.8)
  Unemployed                                 12 (44.4)
  Age at diagnosis, yrs                       
  18--29                                     23 (85.2)
  30--35                                     4 (14.8)
  Acute attacks in the last year              
  0                                          10
  1--5                                       15
  10                                         2
  Without the symptoms between the attacks   18
  With symptoms between the attacks          9
  ------------------------------------------ -----------

Values are *n* (%).

###### 

Clinical manifestations.

  Clinical manifestations (*n* = 27)   
  ------------------------------------ ------------
  Cyclical attacks                     27 (100.0)
  Abdominal pain                       23 (85.2)
  Constipation                         21 (77.8)
  Nausea                               19 (70.4)
  Paresis                              13 (48.1)
  Tachycardia                          11 (40.7)
  Confusion                            8 (29.6)
  Convulsion                           8 (29.6)
  Complaints in intermission           9 (33.3)

Values are *n* (%).

###### 

PCS subscale scores and composite scores with variables.

                        PF score   *P* value   RP score   *P* value   BP score   *P* value   GH score   *P* value   PCS composite   *P* value
  --------------------- ---------- ----------- ---------- ----------- ---------- ----------- ---------- ----------- --------------- -----------
  Education                                                                                                                          
   \<College graduate   88.12      0.21        76.56      0.81        75.56      0.71        58.69      0.09        43.53           0.43
   College graduate     82.27      80.00       80.00      41.45       46.85                                                         
  Marital status                                                                                                                     
   Married              85.53      0.89        73.68      0.23        83.05      0.07        52.42      0.82        41.57           0.17
   Single               86.25      43.75       65.89      49.88       41.24                                                         
  Work status                                                                                                                        
   Stay at home         82.08      0.15        35.42      0.02        82.93      0.21        51.5       0.98        41.57           0.08
   Work                 88.67      88.33       71.75      51.8        48.64                                                         
  Acute attacks                                                                                                                      
   Without attack       92.22      0.04        77.78      0.42        90.22      0.04        65.22      0.05        53.22           0.001
   With attack          82.50      58.33       71.83      44.89       40.45                                                         

###### 

MCS subscale scores and composite scores with variables.

                        VT score   *P* value   SF score   *P* value   RE score   *P* value   MH score   *P* value   MCS composite   *P* value
  --------------------- ---------- ----------- ---------- ----------- ---------- ----------- ---------- ----------- --------------- -----------
  Education                                                                                                                          
   \<College graduate   61.88      0.20        88.28      0.49        64.58      0.61        70.25      0.10        45.98           0.54
   College graduate     52.27      81.81       75.75      57.82       48.99                                                         
  Marital status                                                                                                                     
   Married              57.63      0.89        86.84      0.69        68.42      0.92        62.95      0.36        47.16           0.70
   Single               58.75      82.61       70.83      70.50       49.21                                                         
  Work status                                                                                                                        
   Stay at home         50.83      0.08        80.20      0.08        52.22      0.17        64.33      0.84        44.39           0.20
   Work                 63.67      90.00       82.22      65.87       50.47                                                         
  Acute attacks                                                                                                                      
   Without attack       62.22      0.74        91.67      0.43        59.26      0.83        68.00      0.42        47.12           0.70
   With attack          55.59      83.82       62.75      65.41       47.53                                                         

###### 

Predictors for worsening of PTSD (IES-R subscale scores and composite scores with variables).

  Variable              IES-R   *P* value   Subscales                                  
  --------------------- ------- ----------- ----------- ------- ------- ------ ------- ------
  Education                                                                             
   \<College graduate   34.88   0.42        17.19       0.43    17.69   0.46   12.25   0.22
   College graduate     38.64   19.00       19.00       14.73                          
  Marital status                                                                        
   Married              35.79   0.68        17.53       0.59    18.26   0.79   13.80   0.63
   Single               36.88   18.88       19.00       12.50                          
  Work status                                                                           
   Stay at home         38.67   0.37        18.92       0.43    19.75   0.38   13.92   0.56
   Work                 34.60   17.13       17.47       12.73                          
  Acute attacks                                                                         
   No attack            30.89   0.08        14.44       0.03    16.44   0.24   11.33   0.17
   Have attacks         39.17   19.53       19.71       14.29                          

###### 

SF-36 subscale scores and comparison with norm-based scoring.

  Scale   Scores          Norm-based score (HK *n* = 2410) \[[@B9]\]   *P* value   Norm-based score (mainland, *n* = 11836) \[[@B25]\]   *P* value
  ------- --------------- -------------------------------------------- ----------- ----------------------------------------------------- -----------
  PF      85.74 ± 11.67   91.83                                        0.01        88.8                                                  0.18
  RP      64.81 ± 57.74   82.43                                        0.13        77.7                                                  0.26
  Bp      77.96 ± 22.81   83.98                                        0.18        78.9                                                  0.83
  GH      51.67 ± 25.84   55.98                                        0.39        64.7                                                  0.015
  VT      57.96 ± 18.96   60.27                                        0.53        69.1                                                  0.005
  SF      85.65 ± 23.44   91.19                                        0.23        82.5                                                  0.49
  RE      69.13 ± 54.64   71.67                                        0.81        69.7                                                  0.06
  MH      65.19 ± 19.15   72.79                                        0.049       72.4                                                  0.15
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